Learn about smoldering myeloma and the first treatment approved by the U.S. Food and Drug Administration to prevent its...
In the third post of the “Meet the Chairs” series, Anna Barker, PhD, chair of the AACR Scientist↔Survivor Program...
AACR is the proud Scientific Partner for Stand Up To Cancer (SU2C), and for Colorectal Cancer Awareness Month, we...
On March 7, the AACR co-hosted its first, local advocacy event with the Moffitt Cancer Center in Tampa, Florida....
A recent study in the AACR’s journal Cancer Epidemiology, Biomarkers & Prevention found an association between glycemic index (a...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of crizotinib (Xalkori)...
In the second post of the "Meet the Chairs" series, Mark Stewart, PhD, chair of the AACR's Associate Member...
March is Colorectal Cancer Awareness Month. About 134,490 people are estimated to be diagnosed with and about 49,190 are...
In the first post of the "Meet the Chairs" series, Scott Armstrong, MD, PhD, program chair of the 2016...
While the incidence of many cancer types is decreasing, endometrial cancer—a type of cancer that begins in the uterus...
Guest Post by Lee Gibbs Associate member of the American Association for Cancer Research (AACR) and doctoral candidate at the...